ABIRATERONE ACETATE and DYSPNOEA

779 reports of this reaction

1.4% of all ABIRATERONE ACETATE reports

#16 most reported adverse reaction

Overview

DYSPNOEA is the #16 most commonly reported adverse reaction for ABIRATERONE ACETATE, manufactured by Janssen Biotech, Inc.. There are 779 FDA adverse event reports linking ABIRATERONE ACETATE to DYSPNOEA. This represents approximately 1.4% of all 56,299 adverse event reports for this drug.

Patients taking ABIRATERONE ACETATE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA779 of 56,299 reports

DYSPNOEA is a less commonly reported adverse event for ABIRATERONE ACETATE, but still significant enough to appear in the safety profile.

Other Side Effects of ABIRATERONE ACETATE

In addition to dyspnoea, the following adverse reactions have been reported for ABIRATERONE ACETATE:

DEATH — 6,122 reports
FATIGUE — 2,592 reports
PROSTATIC SPECIFIC ANTIGEN INCREASED — 1,989 reports
DRUG INEFFECTIVE — 1,972 reports
THERAPY CESSATION — 1,557 reports
HOT FLUSH — 1,437 reports
ASTHENIA — 1,277 reports
DISEASE PROGRESSION — 1,189 reports
HOSPITALISATION — 1,067 reports
OFF LABEL USE — 1,060 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

0XYGEN ABEMACICLIB ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 325 MG ACETAMINOPHEN 325MG ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE

Frequently Asked Questions

Does ABIRATERONE ACETATE cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 779 FDA reports for ABIRATERONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with ABIRATERONE ACETATE?

DYSPNOEA accounts for approximately 1.4% of all adverse event reports for ABIRATERONE ACETATE, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking ABIRATERONE ACETATE?

If you experience dyspnoea while taking ABIRATERONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

ABIRATERONE ACETATE Full Profile All Drugs Causing DYSPNOEA Janssen Biotech, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.